4//SEC Filing
Arcadia Biosciences, Inc. 4
Accession 0001209191-16-123347
$RKDACIK 0001469443operating
Filed
May 24, 8:00 PM ET
Accepted
May 25, 7:14 PM ET
Size
14.3 KB
Accession
0001209191-16-123347
Insider Transaction Report
Form 4
KETKAR RAJENDRA D.
Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2016-05-23+225,000→ 225,000 totalExercise: $6.00Exp: 2026-05-22→ Common Stock (225,000 underlying) - Award
Stock Option (right to buy)
2016-05-23+225,000→ 225,000 totalExercise: $8.00Exp: 2026-05-22→ Common Stock (225,000 underlying) - Award
Stock Option (right to buy)
2016-05-23+50,000→ 50,000 totalExercise: $12.00Exp: 2026-05-22→ Common Stock (50,000 underlying) - Award
Stock Option (right to buy)
2016-05-23+50,000→ 50,000 totalExercise: $15.00Exp: 2026-05-22→ Common Stock (50,000 underlying) - Award
Stock Option (right to buy)
2016-05-23+200,000→ 200,000 totalExercise: $1.35Exp: 2026-05-22→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option vests with respect to 25% of the total securities subject to the option on the first anniversary of the date of award, or May 23, 2017, with the remaining 75% vesting in 36 equal installments beginning May 31, 2017 and ending April 30, 2020.
Documents
Issuer
Arcadia Biosciences, Inc.
CIK 0001469443
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001469443
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 7:14 PM ET
- Size
- 14.3 KB